Neuroimaging markers of Alzheimer's disease, mild cognitive impairment and normal healthy ageing
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder clinically characterised by memory loss and cognitive decline that severely affect activities of daily living. Neuropathologically, the disease is characterised by two major proteinopathies, extracellular amyloid-beta (Aβ) plaques...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
King's College London (University of London)
2017
|
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.739982 |